IBM’s Watson Health wing left looking poorly after ‘massive’ layoffs

Up to 70% of staff shown the door this week, insiders claim

IBM has laid off approximately 50 and 70 per cent of staff this week in its Watson Health division, according to inside sources.

The axe, we’re told, is largely falling on IBMers within companies the IT goliath has taken over in the past few years to augment Watson’s credentials in the health industry. These include medical data biz Truven, which was acquired in 2016 for $2.6bn, medical imaging firm Merge, bought in 2015 for $1bn, and healthcare management business Phytel, also snapped up in 2015.

Yesterday and today, staff were let go at IBM’s offices in Dallas, Texas, as well as in Ann Arbor, Michigan, Cleveland, Ohio, and Denver, Colorado, in the US, and elsewhere, it is claimed. A spokesperson for Big Blue was not available for comment.

“Wanted to share anonymously a massive layoff in Watson Health, potentially limited to provider acquisitions – Phytel, Explorys, Truven,” a source claimed in a message passed to The Register by Lee Conrad, a former employee and union coordinator who today runs the Watching IBM Facebook page.

“They are laying off 50 to 70 per cent of staff. Not sure about total affected since there’s no transparency, but our Dallas office has 230 people.”

Another worker said: “IBM Watson Health has initiated a significant RA [resource action aka layoffs] across multiple offices. The provider division in Dallas has seen at least 80 per cent affected, and 30 per cent in the Truven customer experience group. Awaiting confirmation of details on severance packages, but can confirm this was broad and not targeted at a specific demographic.”

Indeed, it appears new and longterm staff are affected by the cuts. “Over 50 years old. IBMer over 30 years,” said one. “The message was that there are about 7,000 people in Watson Health today and this was a cost-cutting exercise. 90 days’ notice with 30 days’ severance.”

By Iain Thomson | The Register

Image Credit: Iain Thomson / The Register

READ MORE

About Peter Coffaro 464 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.